Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

1 September 2024 (08:48 - 09:00)
Organised by: Logo
Congress Presentation Part of: Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology